374633-24-6 Usage
Uses
Used in Organic Synthesis:
1-Bromo-2,3-difluoro-5-nitrobenzene is utilized as a building block in organic synthesis for the preparation of various pharmaceuticals and agrochemicals. Its unique combination of functional groups allows for versatile chemical reactions, making it a valuable component in the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-Bromo-2,3-difluoro-5-nitrobenzene serves as an intermediate for the development of new pharmaceuticals. Its structural features can be modified to create compounds with specific biological activities, contributing to the discovery of novel therapeutic agents.
Used in Dye and Pigment Production:
1-Bromo-2,3-difluoro-5-nitrobenzene is also employed as an intermediate in the production of dyes and pigments. Its chemical properties enable the creation of a wide range of colorants used in various industries, including textiles, plastics, and printing inks.
Used in Chemical Research:
Due to its unique structure and reactivity, 1-Bromo-2,3-difluoro-5-nitrobenzene is a valuable compound for chemical research. It can be used to study reaction mechanisms, explore new synthetic routes, and develop innovative applications in various chemical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 374633-24-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,4,6,3 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 374633-24:
(8*3)+(7*7)+(6*4)+(5*6)+(4*3)+(3*3)+(2*2)+(1*4)=156
156 % 10 = 6
So 374633-24-6 is a valid CAS Registry Number.
374633-24-6Relevant articles and documents
LIPOXYGENASE INHIBITORS
-
Paragraph 00355, (2021/07/02)
Various embodiments of the present disclosure are directed to compounds having Formula I, Formula II, Formula IIA, Formula III, Formula IIIA, Formula IIIB, and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases and/or treating associated diseases. In some embodiments, subject compounds are used to prepare a composition that is effective in treating neurodegenerative diseases.
Preparation method of 2-bromo-6-fluoroanisole
-
Paragraph 0025; 0027-0028; 0037; 0039-0040; 0047; 0049-0050, (2021/09/11)
The invention discloses a preparation method of 2-bromine-6-fluoroanisole, the preparation method comprises the following specific steps: (1) carrying out electrophilic substitution reaction on 3, 4-difluoronitrobenzene and bromosuccinimide to generate a compound III; (2) reacting the compound III with sodium methoxide to generate a compound IV; (3) reducing the compound IV by sodium hydrosulfite to generate a compound V; (4) performing diazotization deamination on the compound V to generate a compound I; the obtained product is 2-bromo-6-fluoroanisole. The preparation method is higher in yield.
IMIDAZOLINYLMETHYL ARYL SULFONAMIDE
-
Page/Page column 5, (2009/08/16)
This invention relates to an alpha-1A receptor partial agonist, which is represented by Formula I: and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing formula I, methods for th
